PMV PHARMACEUTICALS, INC. Cash
PMV PHARMACEUTICALS, INC. (PMVP) had Cash of $254.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2023-11-09
- 2023-09-30: Cash $254.00K.
- 2023-06-30: Cash $3.52M.
- 2023-03-31: Cash $6.05M.
- 2022-12-31: Cash $1.44M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2023-09-30 | $254.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.52M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $6.05M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $1.44M 10-Q · filed 2023-11-09 | |
| 2022-09-30 | $1.50M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $3.32M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.50M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $3.51M 10-K · filed 2023-03-01 | $3.51M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |